Literature DB >> 26169165

Neurological manifestations in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis in the Amazon.

G A S Dias1, G T Yoshikawa2, R V L Koyama3, S Fujihara3, L C S Martins4, R Medeiros1, J A S Quaresma3, H T Fuzii1.   

Abstract

STUDY
DESIGN: A cross-sectional observational study was conducted.
OBJECTIVE: The aim was to analyze the clinical-functional profile of patients diagnosed with HTLV-1 (human T-lymphotropic virus type 1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in the Amazon region.
SETTING: Reference center for HTLV in the city of Belém, state of Pará, Brazil.
METHODS: Muscle strength, muscle tone, balance and the need for gait assistance among patients with HAM/TSP were evaluated.
RESULTS: Among the 82 patients infected with HTLV-1, 27 (10 men and 17 women) were diagnosed with HAM/TSP. No statistically significant difference in muscle tone or strength was found between the lower limbs. Muscle weakness and spasticity were predominant in the proximal lower limbs. Patients with HAM/TSP are at a high risk of falls (P=0.03), and predominantly use either a cane or a crutch on one side as a gait-assistance device (P=0.02).
CONCLUSION: Patients with HAM/TSP exhibit a similar clinical pattern of muscle weakness and spasticity, with a high risk of falls, requiring gait-assistance devices.

Entities:  

Mesh:

Year:  2015        PMID: 26169165     DOI: 10.1038/sc.2015.112

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  25 in total

Review 1.  The HTLV-1 neurological complex.

Authors:  Abelardo Q C Araujo; Marcus Tulius T Silva
Journal:  Lancet Neurol       Date:  2006-12       Impact factor: 44.182

2.  Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

Authors:  Carlos M De Castro-Costa; Abelardo Q C Araújo; Márcio M Barreto; Osvaldo M Takayanagui; Marzia P Sohler; Eduardo L M da Silva; Sônia M B de Paula; Ricardo Ishak; João G R Ribas; Luis C Rovirosa; Herwig Carton; Eduardo Gotuzzo; William W Hall; Silvia Montano; Edward L Murphy; Joel Oger; Carlos Remondegui; Graham P Taylor
Journal:  AIDS Res Hum Retroviruses       Date:  2006-10       Impact factor: 2.205

3.  Implications of HAM/TSP functional incapacity in the quality of life.

Authors:  Marcia Shublaq; Marco Orsini; Marzia Puccioni-Sohler
Journal:  Arq Neuropsiquiatr       Date:  2011-04       Impact factor: 1.420

Review 4.  [Human T cell lymphotropic virus (HTLV-1): when to suspect infection?].

Authors:  Luiz Cláudio Ferreira Romanelli; Paulo Caramelli; Anna Barbara de Freitas Carneiro Proietti
Journal:  Rev Assoc Med Bras (1992)       Date:  2010 May-Jun       Impact factor: 1.209

5.  Performance-oriented assessment of mobility problems in elderly patients.

Authors:  M E Tinetti
Journal:  J Am Geriatr Soc       Date:  1986-02       Impact factor: 5.562

6.  Falls in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  L D Facchinetti; A Q Araújo; G L Chequer; M F de Azevedo; R V C de Oliveira; M A Lima
Journal:  Spinal Cord       Date:  2012-11-20       Impact factor: 2.772

Review 7.  HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.

Authors:  Denise U Goncalves; Fernando A Proietti; Edel F Barbosa-Stancioli; Marina L Martins; João G Ribas; Olindo A Martins-Filho; Andrea Teixeira-Carvalho; Vanessa Peruhype-Magalhães; Anna B Carneiro-Proietti
Journal:  Inflamm Allergy Drug Targets       Date:  2008-06

8.  The elevated interferon gamma production is an important immunological marker in HAM/TSP pathogenesis.

Authors:  P A Montanheiro; A C Penalva de Oliveira; J Smid; L M I Fukumori; I Olah; A J da S Duarte; J Casseb
Journal:  Scand J Immunol       Date:  2009-10       Impact factor: 3.487

9.  Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients.

Authors:  Rosita Vakili; Faezeh Sabet; Sanaz Aahmadi; Reza Boostani; Houshang Rafatpanah; Ali Shamsian; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

Review 10.  "HTLV-I Infection" Twenty-Year Research in Neurology Department of Mashhad University of Medical Sciences.

Authors:  Ali Shoeibi; Mohammdmahdi Etemadi; Amir Moghaddam Ahmadi; Mona Amini; Reza Boostani
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

View more
  8 in total

1.  Incomplete myelopathy and human T cell lymphotropic virus type-1 (HTLV-1).

Authors:  Roberta Vilela Lopes Koyama; Gilberto Toshimitsu Yoshikawa; Satomi Fujihara; George Alberto da Silva Dias; Rodrigo Rodrigues Virgolino; Anderson Raiol Rodrigues; Rita Medeiros; Juarez Antônio Simões Quaresma; Hellen Thaís Fuzii
Journal:  J Neurovirol       Date:  2018-10-05       Impact factor: 2.643

2.  Spasticity distribution and severity in individuals with HTLV-1-associated myelopathy/tropical spastic paraparesis.

Authors:  Matheus Sales; Giselle Bárbara de Almeida Scaldaferri; Juliana Iris Barbosa Dos Santos; Ailton Melo; Nildo Manoel da Silva Ribeiro
Journal:  J Neurovirol       Date:  2020-10-06       Impact factor: 2.643

Review 3.  The challenge of describing the epidemiology of HTLV in the Amazon region of Brazil.

Authors:  Ricardo Ishak; Marluísa de Oliveira Guimarães Ishak; Antonio Carlos R Vallinoto
Journal:  Retrovirology       Date:  2020-02-14       Impact factor: 4.602

4.  Therapeutic effects of virtual reality video gaming on functional mobility, balance, and gait speed in individuals with tropical spastic paraparesis: A randomized crossover clinical trial.

Authors:  Erika Pedreira da Fonseca; Katia Nunes Sá; Rebeca Freitas Reis Nunes; Camille Rosa de Jesus Souza; Mayra Castro de Matos Sousa; Elen Beatriz Pinto
Journal:  Rev Soc Bras Med Trop       Date:  2021-01-29       Impact factor: 1.581

5.  Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis.

Authors:  Naiane Araújo Patrício; Mônica Andrade Rios; Patrícia Carvalho Barbosa; Jéssica Ramos Ribeiro; Diogo Guedes Vidal; Kátia Nunes Sá; Abrahão Fontes Baptista
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-25       Impact factor: 1.581

6.  Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.

Authors:  Flávia Dos Santos Souza; Nicole Lardini Freitas; Yago Côrtes Pinheiro Gomes; Rafael Carvalho Torres; Juliana Echevarria-Lima; Isaac Lima da Silva-Filho; Ana Claudia Celestino Bezerra Leite; Marco Antonio Sales Dantas de Lima; Marcus Tulius Teixeira da Silva; Abelardo de Queiroz Campos Araújo; Otávio Melo Espíndola
Journal:  Front Immunol       Date:  2021-10-26       Impact factor: 7.561

7.  Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection.

Authors:  Beatriz Helena B Vasconcelos; Givago S Souza; Tatiana G C P Barroso; Luiz Carlos L Silveira; Rita Catarina M Sousa; Bianca Callegari; Marília B Xavier
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

8.  Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis.

Authors:  Pablo Julca-Copello; Alvaro Schwalb; Rodrigo Cachay; Martín Tipismana; Carolina Alvarez; Fernando Mejía; Elsa González-Lagos; Eduardo Gotuzzo
Journal:  Rev Soc Bras Med Trop       Date:  2020-09-11       Impact factor: 1.581

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.